Capital Impact Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,280
| Closed | -$464K | – | 99 |
|
|
2023
Q4 | $464K | Hold |
24,280
| – | – | 0.61% | 78 |
|
|
2023
Q3 | $436K | Buy |
24,280
+2,411
| +11% | +$43.3K | 0.73% | 66 |
|
|
2023
Q2 | $444K | Buy |
21,869
+1,368
| +7% | +$27.8K | 0.49% | 103 |
|
|
2023
Q1 | $374K | Buy |
20,501
+4,344
| +27% | +$79.2K | 0.46% | 103 |
|
|
2022
Q4 | $334K | Buy |
16,157
+7,757
| +92% | +$160K | 0.33% | 131 |
|
|
2022
Q3 | $241K | Buy |
8,400
+331
| +4% | +$9.5K | 0.24% | 163 |
|
|
2022
Q2 | $204K | Buy |
+8,069
| New | +$204K | 0.19% | 197 |
|